The present results suggest that since the expression of angiogenesis factors is elevated during HCC tumorigenesis, it is reasonable that expression of angiogenesis inhibitors such as endostatin/C18 is decreased in HCC patients. This evidence concerns the gene COL18A1 and hepatocellular carcinoma.